alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>   1

                                   EXHIBIT 5.1


                               OPINION OF COUNSEL
   
         I have acted as counsel for Ride, Inc., a Washington corporation (the
"Company"), in connection with the preparation and filing of this Registration
Statement on Form S-3 (the "Registration Statement"), under the Securities Act
of 1933, as amended. The Registration Statement covers 2,608,729 shares of
Common Stock, no par value, of the Company plus up to 2,006,480 additional
shares of Common Stock that may become issuable upon conversion of the Series B
Preferred Stock pursuant to provisions of the Certificate of Designation for
the Series B Preferred Stock and upon exercise of the warrants pursuant to
certain provisions therein (collectively, the "Stock"), which may be sold by
the "Selling Shareholders".

         As General Counsel for the Company, I have reviewed the corporate
actions of the Company in connection with this matter and have examined the
documents, corporate records and other instruments deemed necessary for the
purpose of this opinion.

         Based on the foregoing, it is my opinion that:

         (I) The Company is a corporation duly incorporated and validly existing
under the laws of the State of Washington; and

         (II) The Stock being registered has been duly authorized and validly
issued and is fully paid and nonassessable.

         I consent to the filing of this opinion as Exhibit 5.1 to the
Registration Statement and to the reference to me under the caption "Legal
Matters" in the Prospectus which is part of the Registration Statement.


March 24, 1998
    


/s/ David H. Davis 
-------------------------------
David H. Davis, General Counsel
and Corporate Secretary
<PAGE>   1


                  EXHIBIT 21.1   SUBSIDIARIES OF THE REGISTRANT

List of Subsidiaries of the Company


NAMES OF SUBSIDIARIES UNDER WHICH THEY DO BUSINESS:     STATE OF INCORPORATION:
---------------------------------------------------     -----------------------

AMT Environmental Products Inc. ("AMT")                 British Columbia, Canada

PSI Acquisitions Corp. ("PAC")                          British Columbia, Canada

Alternative Materials Technology, Inc. (AMT "USA")      Chico, California
<PAGE>

                         HANSEN, HUNTER & KIBBEE, P.C.
                          CERTIFIED PUBLIC ACCOUNTANTS
                           10260 S.W. Greenburg Road
Telephone                          Suite 1150                        Facsimile
(503) 244-2134                Portland, Oregon 97223            (503) 244-9754




                 CONSENT OF HANSEN, HUNTER & KIBBEE, P.C.



We consent to the incorporation by reference in this Amended Annual Report on 
Form 10-K/A, filed with the Securities and Exchange Commission by NHP 
Incorporated (NHP) of our reports dated, January 19, 1995, January 13, 1995, 
January 19, 1995, January 13, 1995, January 19, 1995, January 11, 1995, 
January 14, 1995, and January 13, 1995 with respect to the audits of Haines 
Associates Limited Partnership, King-Bell Associates, Monmouth Associates 
Limited Partnership, Pendleton Riverside Apartments Oreg., Ltd., Penn Hall 
Associates, Rodeo Drive Limited Partnership, South Mountain Terrace, Ltd., 
and Woodland Apartments, Oreg., Ltd. for the year ended December 31, 1994, 
and the incorporation by reference of such reports into NHP's Registration 
Statement on Form S-8 (No. 333-11933), NHP's Registration Statement on Form 
S-8 (No. 333-11863), NHP's Registration Statement on Form S-8 (333-11917), 
NHP's Registration Statement on Form S-8 (333-11857), and NHP's Registration 
Statement on Form S-8 (333-08137).

/s/ Hansen, Hunter & Kibbee, P.C.

Portland, Oregon
October 3, 1997
118TH CONGRESS 

2D SESSION H. R. 7199 

AN ACT 

To designate the facility of the United States Postal Service 

located at S74w16860 Janesville Road, in Muskego, Wisconsin, as the ‘‘Colonel Hans Christian Heg Post Office’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 7199 EH

1 SECTION 1. COLONEL HANS CHRISTIAN HEG POST OFFICE. 

2 (a) DESIGNATION.—The facility of the United States 

3 Postal Service located S74w16860 Janesville Road in 

4 Muskego, Wisconsin, shall be known and designated as the 

5 ‘‘Colonel Hans Christian Heg Post Office’’. 

6 (b) REFERENCES.—Any reference in a law, map, reg7 ulation, document, paper, or other record of the United 

8 States to the facility referred to in subsection (a) shall 

9 be deemed to be a reference to the ‘‘Colonel Hans Chris10 tian Heg Post Office’’. 

Passed the House of Representatives June 3, 2024. 

Attest: 

Clerk. 

118TH CONGRESS 

2D SESSION H. R. 7199 

AN ACT 

To designate the facility of the United States PostChristian Heg Post Office’’. in Muskego, Wisconsin, as the ‘‘Colonel Hans al Service located at S74w16860 Janesville Road,
<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                                   1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-mos
<FISCAL-YEAR-END>                              Dec-31-1998
<PERIOD-START>                                 Jan-01-1998
<PERIOD-END>                                   Dec-31-1998
<CASH>                                         10,166
<SECURITIES>                                   0
<RECEIVABLES>                                  617
<ALLOWANCES>                                   0
<INVENTORY>                                    980
<CURRENT-ASSETS>                               14,802
<PP&E>                                         18,826
<DEPRECIATION>                                 (14,786)
<TOTAL-ASSETS>                                 47,394
<CURRENT-LIABILITIES>                          14,657
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    4
<COMMON>                                       150
<OTHER-SE>                                     13,103
<TOTAL-LIABILITY-AND-EQUITY>                   47,394
<SALES>                                        445
<TOTAL-REVENUES>                               3,652
<CGS>                                          0
<TOTAL-COSTS>                                  23,362
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             (708)
<INCOME-PRETAX>                                (20,022)
<INCOME-TAX>                                   2,159
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (17,863)
<EPS-PRIMARY>                                  1.23
<EPS-DILUTED>                                  0
        


</TABLE>
EXHIBIT 23.1

                          Independent Auditors' Consent

To the Board of Directors and Shareholders of Footstar, Inc.:

We consent to incorporation by reference in the registration statements (No.
333-20731, No. 333-30011 and No. 333-41390) on Form S-8 of Footstar, Inc. of our
report dated February 12, 2001, relating to the consolidated balance sheets of
Footstar, Inc. and Subsidiary Companies as of December 30, 2000 and January 1,
2000 and the related consolidated statements of operations, shareholders' equity
and comprehensive income and cash flows for each of the years in the three-year
period ended December 30, 2000 and the related schedule, which report appears or
is incorporated by reference in the December 30, 2000 Annual Report on Form 10-K
of Footstar, Inc.

/s/ KPMG LLP

Short Hills, NJ
March 30, 2001
§ 349.50 Labeling of ophthalmic drug products. ( a ) The word “physician” may be substituted for the word “doctor” in any of the labeling statements in this part.
( b ) Where applicable, indications in this part applicable to each ingredient in the product may be combined to eliminate duplicative words or phrases so that the resulting information is clear and understandable. Other truthful and nonmisleading statements, describing only the indications for use that have been established and listed in this part, may also be used, as provided in § 330.1(c)(2), subject to the provisions of section 502 of the act relating to misbranding and the prohibition in section 301(d) of the act against the introduction or delivery for introduction into interstate commerce of unapproved new drugs in violation of section 505(a) of the act.
( c ) The labeling of the product contains the following warnings, under the heading “Warnings”: ( 1 ) *For ophthalmic drug products packaged in multi-use containers.* “To avoid contamination, do not touch tip of container to any surface. Replace cap after using.”
( 2 ) *For ophthalmic drug products packaged in single-use containers.* “To avoid contamination, do not touch tip of container to any surface. Do not reuse. Once opened, discard.”
( 3 ) *For ophthalmic drug products containing mercury compounds used as a preservative.* “This product contains (name and quantity of mercury-containing ingredient) as a preservative. Do not use this product if you are sensitive to” (select one of the following: “mercury” or “(insert name of mercury-containing ingredient) or any other ingredient containing mercury).”
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-28-1999
<PERIOD-START>                             MAR-30-1998
<PERIOD-END>                               DEC-27-1998
<CASH>                                           1,356
<SECURITIES>                                         0
<RECEIVABLES>                                    7,544
<ALLOWANCES>                                         0
<INVENTORY>                                      5,519
<CURRENT-ASSETS>                                15,608
<PP&E>                                          91,043
<DEPRECIATION>                                (82,352)
<TOTAL-ASSETS>                                  24,618
<CURRENT-LIABILITIES>                           15,412
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            30
<OTHER-SE>                                      70,423
<TOTAL-LIABILITY-AND-EQUITY>                    24,618
<SALES>                                          9,755
<TOTAL-REVENUES>                                 9,755
<CGS>                                            5,901
<TOTAL-COSTS>                                    5,901
<OTHER-EXPENSES>                                 3,796
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 246
<INCOME-PRETAX>                                  (188)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              (188)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (188)
<EPS-PRIMARY>                                   (0.07)
<EPS-DILUTED>                                   (0.07)
        

</TABLE>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   YEAR                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996             DEC-31-1995
<PERIOD-START>                             JAN-01-1996             JAN-01-1995
<PERIOD-END>                               DEC-31-1996             DEC-31-1995
<CASH>                                           8,291                  44,703
<SECURITIES>                                    23,774                       0
<RECEIVABLES>                                        0                       0
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                33,362                  44,975
<PP&E>                                           3,722                   2,172
<DEPRECIATION>                                   1,746                   1,298
<TOTAL-ASSETS>                                  35,485                  45,919
<CURRENT-LIABILITIES>                            2,927                   1,770
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                            12                      12
<OTHER-SE>                                      31,753                  44,023
<TOTAL-LIABILITY-AND-EQUITY>                    35,485                  45,919
<SALES>                                            137                       0
<TOTAL-REVENUES>                                   137                       0
<CGS>                                              319                       0
<TOTAL-COSTS>                                        0                       0
<OTHER-EXPENSES>                                14,818                   8,252
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                                (12,879)                 (7,106)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                                  0                       0
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                   (12,879)                 (7,106)
<EPS-PRIMARY>                                    (1.04)                  (0.71)
<EPS-DILUTED>                                    (1.04)                  (0.71)


</TABLE>
##### 



EXHIBIT
4.12
 AMENDMENT NO. 1 TO THE
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION
 THIS AMENDMENT NO. 1 TO THE AGREEMENT AND PLAN OF MERGER AND REORGANIZATION
 RECITALS
 WHEREAS
 WHEREAS
 NOW, THEREFORE,
 Amendments to the Agreement.
  Pre-Closing Tax
Return Post-Closing Tax Return
    Conversion of Company Preferred Stock




---



##### 



Preferred Exchange Rate
 Section 4.2 of Company Disclosure Schedule Attachment A
 No Further Modification
 Choice of Law
 Binding Effect
 Headings/Defined Terms
 Counterparts
 [Signature pages follow.]
 2




---



##### 



IN WITNESS WHEREOF
 PTI:
    
    PROTHERICS PLCBy:
    
    /s/ B. M. RileyName:
    
    Barrington Marshall RileyTitle:
    
    Finance DirectorPTI MERGER SUB:
    
    MACROMED ACQUISITION CORP.By:
    
    /s/ B. M. RileyName:
    
    Barrington Marshall RileyTitle:
    
    Finance DirectorTHE COMPANY:
    
    MACROMED, INC.By:
    
    /s/ T. BergmannName:
    
    Thomas BergmanTitle:
    
    CEOJOINDER PARTIES:
    
    JACQUES GONELLA, Ph.D./s/ J. GonellaSUNG WAN KIM, Ph.D./s/ Sung Wan KimLEONARD JACOB/s/ Leonard S. JacobSAMYANG CORPORATION,a Republic of Korea corporationBy:
    
    /s/ Dongho LeeName:
    
    Dongho Lee, Ph.D., M.D.Title:
    
    Executive Vice President
 3




---



##### 



SAMYANG GENEX CORPORATION,a Republic of Korea corporationBy:
    
    /s/ Rang KimName:
    
    Rang KimTitle:
    
    President and CEO
 4
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUN-30-1997
<PERIOD-START>                             JUL-01-1996
<PERIOD-END>                               MAR-31-1997
<CASH>                                           8,965
<SECURITIES>                                     4,685
<RECEIVABLES>                                    1,539
<ALLOWANCES>                                         0
<INVENTORY>                                         89
<CURRENT-ASSETS>                                15,965
<PP&E>                                           5,734
<DEPRECIATION>                                   4,088
<TOTAL-ASSETS>                                  21,169
<CURRENT-LIABILITIES>                            4,700
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            55
<OTHER-SE>                                      15,918
<TOTAL-LIABILITY-AND-EQUITY>                    21,169
<SALES>                                          1,718
<TOTAL-REVENUES>                                 3,534
<CGS>                                              366
<TOTAL-COSTS>                                    1,025
<OTHER-EXPENSES>                                 2,423
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                    251
<INCOME-TAX>                                        91
<INCOME-CONTINUING>                                161
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       161
<EPS-PRIMARY>                                      .03
<EPS-DILUTED>                                      .03
        

</TABLE>
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7204 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7204

 To amend the Water Resources Development Act of 2007 with respect to 
the Susquehanna, Delaware, and Potomac River Basin Commissions, and for 
                            other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 1, 2024

 Mr. Molinaro (for himself, Ms. Houlahan, Mr. Fitzpatrick, Mr. Evans, 
 and Ms. Scanlon) introduced the following bill; which was referred to 
           the Committee on Transportation and Infrastructure

_______________________________________________________________________

                                 A BILL

 
 To amend the Water Resources Development Act of 2007 with respect to 
the Susquehanna, Delaware, and Potomac River Basin Commissions, and for 
                            other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Ensure Funding for Our Environment 
Act''.

SEC. 2. SUSQUEHANNA, DELAWARE, AND POTOMAC RIVER BASIN COMMISSIONS.

    Section 5019 of the Water Resources Development Act of 2007 (121 
Stat. 1201; 128 Stat. 1307) is amended--
            (1) in subsection (a)(3), by inserting ``, who may be the 
        Administrator of the Environmental Protection Agency (referred 
        to in this section as the `Administrator') (or a designee),'' 
        after ``member''; and
            (2) in subsection (b)--
                    (A) in paragraph (1), by striking ``The Secretary'' 
                and inserting ``Subject to the availability of 
                appropriations, the Administrator'';
                    (B) in paragraph (2), by striking ``For each fiscal 
                year, the Secretary'' and inserting ``Subject to the 
                availability of appropriations, for each fiscal year, 
                the Administrator''; and
                    (C) in paragraph (3), by striking ``Secretary'' 
                each place it appears and inserting ``Administrator''.
                                 <all>
```
NO. 06-14-00208-CR

STATE OF TEXAS § IN THE

§

VS. § 6TH COURT

§

TONY DEWAYNE CRAYTON § OF APPEALS

MOTION TO FILE LATE APPELLANT'S BRIEF 

TO THE HONORABLE JUSTICES OF SAID COURT: 

Now comes Tony Dewayne Crayton, Appellant in the above styled and 

numbered cause, and moves this Court to grant an extension of time to file 

appellant's brief, pursuant to Rule 38.6 of the Texas Rules of Appellate Procedure, 

and for good cause shows the following: 

1. This case is on appeal from the 8th Judicial District Court of Hopkins 

County, Texas. 

2. The case below was styled the STATE OF TEXAS vs. Tony Dewayne 

Crayton, and numbered 1323670. 

3. Appellant was convicted of Murder. 

4. Appellant was assessed a sentence of 50 years on November 24, 2014. 

5. Notice of appeal was given on November 24, 2014. 

6. The clerk's record was filed on March 26, 2015; the reporter's record 

was filed on January 27, 2015. 

ACCEPTED

06-14-00208-CR

SIXTH COURT OF APPEALS

TEXARKANA, TEXAS

7/13/2015 12:00:00 AM

DEBBIE AUTREY

CLERK

 FILED IN 6th COURT OF APPEALS TEXARKANA, TEXAS 7/13/2015 9:07:00 AM DEBBIE AUTREY Clerk
7. The appellate brief is presently due on July 8, 2015

8. Appellant requests permission to file late brief.

9. Appellant’s counsel was ordered to file the brief in this case by July 8, 

2015.

10. Appellant’s counsel’s mother was admitted into Hopkins County 

Memorial Hospital and had emergency appendectomy surgery on July 6, 2015.

11. Appellant’s counsel’s mother suffered from complications from the 

surgery and underwent a second surgery on July 10, 2015.

12. The unforeseen circumstance regarding Appellant’s counsel’s medical 

condition made him unable to work on the brief for several days leading up to and 

following the deadline for filing the brief. 

13. Appellant files this motion not for the purpose of delay but to see that 

justice is done.

WHEREFORE, PREMISES CONSIDERED, Appellant prays that this 

Court grant this Motion To File Late Appellant's Brief, and for such other and 

further relief as the Court may deem appropriate.

Respectfully submitted,

Martin Braddy Attorney at Law

121 Oak Avenue

Suite A

Sulphur Springs, Texas 75482

Tel: (903) 885-2040

Fax: (903) 500-2704
By: /s/ Martin Braddy

Martin Braddy

State Bar No. 00796240

martin.braddy@verizon.net

Attorney for Tony Dewayne Crayton

CERTIFICATE OF SERVICE

This is to certify that on July 11, 2015, a true and correct copy of the above 

and foregoing document was served on the District Attorney's Office, Hopkins 

County, 110 Main Street Sulphur Springs, Texas 75482, by E-mail.

/s/ Martin Braddy

Martin Braddy
§ 520.2134 Spinosad and milbemycin. ( a ) *Specifications.* Each chewable tablet contains 140 milligrams (mg) spinosad and 2.3 mg milbemycin oxime, 270 mg spinosad and 4.5 mg milbemycin oxime, 560 mg spinosad and 9.3 mg milbemycin oxime, 810 mg spinosad and 13.5 mg milbemycin oxime, or 1,620 mg spinosad and 27 mg milbemycin oxime.
( b ) *Sponsor.* See No. 058198 in § 510.600 of this chapter.
( c ) *Conditions of use in dogs* — ( 1 ) *Amount.* Administer once a month at a minimum dosage of 13.5 mg/pound (lb) (30 mg/kilogram (kg)) of body weight spinosad and 0.2 mg/lb (0.5 mg/kg) of body weight milbemycin oxime.
( 2 ) *Indications for use.* To kill fleas; for the prevention and treatment of flea infestations (*Ctenocephalides felis*); for the prevention of heartworm disease (*Dirofilaria immitis*); and for the treatment and control of adult hookworm (*Ancylostoma caninum*), adult roundworm (*Toxocara canis* and *Toxascaris leonina*), and adult whipworm (*Trichuris vulpis*) infections in dogs and puppies 8 weeks of age or older and 5 lbs of body weight or greater.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[76 FR 12563, Mar. 8, 2011, as amended at 81 FR 48702, July 26, 2016]